Liver disease treating pill and processing method thereof

Abstract

The invention discloses a liver disease treating pill and a processing method thereof; the pill, which is prepared from radix astragali, cinnabar, Chinese wolfberry fruit, angelica, honeysuckle, radix bupleuri, radix-polygoni multiflori, radix gentianae, herba artemisiae, herba patriniae, fructus schizandrae, carapax amydae and date honey, is characterized in that the materials accountt for the following portions by weight: 12-18 portions of radix astragali, 5-15 portions of Chinese wolfberry fruit, 5-15 portions of angelica, 8-15 portions of honeysuckle, 5-15 portions of radix bupleuri, 4-10 portions of radix-polygoni multiflori, 2-8 portions of radix gentianae, 3-10 portions of herba artemisiae, 3-6 portions of herba patriniae, 3-6 portions of fructus schizandrae, and 2-5 portions of carapax amydae; all materials of respective parts by weight are respectively ground into fine powder, mixed together, heated at the temperature of 100 DEG C for 45 minutes, and then cooled to normal temperature, added with 4-10 portions of date honey, mixed evenly, and finally put into a granulator and prepared into medical pills with a diameter of 2mm.

Description

1. Technical field [0001] The invention relates to the field of medicine, in particular to a Yugan pill for treating hepatitis and a processing method thereof. 2. Background technology [0002] At present, the methods for treating liver diseases are mainly divided into western medicine and traditional Chinese medicine. These two types of methods each have specific medicines whose main function is to suppress the virus and alleviate the condition. There are still certain defects in the specific application of curing liver diseases. Mainly reflected in: (1) Some drugs have negative effects on the patient's body while treating liver inflammation, reducing the body's immune function and causing certain damage to some internal organs including the liver; (2) Some drugs are used During the period, although the transaminase and other indicators were well controlled, the B-ultrasound showed that the liver essence failed to develop in a good direction. Once the drug was stopped, the ...

AI Technical Summary

Problems solved by technology

Mainly reflected in: (1) Some drugs have negative effects on the patient's body while treating liver inflammation, reducing the body's immune function and causing certain damage to some internal organs including the liver; (2) Some drugs are used During the period, although the transaminase and other indicators were well controlled, the B-ultrasound showed that the liver essence failed to develop in a good direction. Once the drug was stopped, the disease would rebound, the virus would replicate rapidly, and the liver function would deteriorate faster; (3) Although some drugs were used To a certain extent, it inhibits virus replication and alleviates the progression of the disease, but the drug resistance of the virus is enhanced during the medication process, and the virus is further mutated, which increases the difficulty of subsequent treatment; (4) most treatment methods can only delay the rate of deterioration and cannot Reverse liver cirrhosis patients; (5) The cost of treatment is high, and the burden of treatment is heavy for patients